Press Release

Printer Friendly Version View printer-friendly version
<< Back
Notice of Cipher Pharmaceuticals Q1 2017 Conference Call & Annual Meeting

MISSISSAUGA, ON, April 27, 2017 /CNW/ - Cipher Pharmaceuticals Inc. (CPH.TO) ("Cipher" or "the Company") today announced the details of its Q1 2017 financial results conference call and Annual Meeting of shareholders on Thursday, May 11, 2017.

Q1 2017 CONFERENCE CALL

WHEN: Thursday, May 11, 2017 at 8:30AM ET

CONFERENCE CALL/WEBCAST: You can join the call by dialing 647-427-7450 or 1-888-231-8191. A live audio webcast will be available through www.cipherpharma.com or http://bit.ly/2oGtdjK. An archived replay of the webcast will be available for 90 days.

ANNUAL MEETING

WHEN: Thursday, May 11, 2017 at 11:00AM ET

WHERE: Goodmans LLP, Bay Adelaide Centre, 333 Bay Street, Suite 3400, Toronto, Ontario,
M5H 2S7

WEBCAST: A live audio webcast and presentation will be available through www.cipherpharma.com or http://bit.ly/2qiNxcq. An archived replay of the webcast will be available for 90 days.

About Cipher Pharmaceuticals Inc.

Cipher (CPH.TO) is a specialty pharmaceutical company with a robust and diversified portfolio of commercial and early to late-stage products. Cipher acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and markets those products either directly in Canada and the U.S. or indirectly through partners in Canada, the U.S., and South America. For more information, visit www.cipherpharma.com.

For more information, please contact:

Craig Armitage
LodeRock Advisors
(416) 347-8954
craig.armitage@loderockadvisors.com